GERI PLUS
THE GERI PLUS INCUBATOR HAS REVOLUTIONIZED EMBRYO CULTURE WITH ITS TECNOLOGY
WHAT DOES THIS TECHNOLOGY CONSISTS IN?
Geri Plus has revolutionized embryo culture. Once the ovule has been inseminated, it begins to divide into smaller and smaller cells until it is transferred into the mother’s uterus.
This process is carried out in the first days of the life of the embryo in an artificial incubator. Hence the importance of keeping homogeneous and optimal conditions for its development. The new technology that incorporates the Geri Plus incubator allows a personalized control of patient’s embryos and a better classification according to their development.
The embryo continues its fascinating evolution while it is comfortable and safe, and our team of embryologists can observe these exciting moments from the outside. The Geri Plus incubator is the latest Time-Lapse technology in embryo culture which allows improving the rates of pregnancy and implantation.
WHY DOES IT ALLOW A BETTER EMBRYO SELECTION?
Geri Plus contributes the Eeva system , which is an early diagnostic method to evaluate embryo viability, thus allowing classifying the embryos depending on their potential to develop to the blastocyste stage and then be implanted.
Unlike other equipment, Geri Plus has 6 independent incubators personalized for each patient, without interfering while the other patients’ embryos are being checked.
A high resolution camera captures images of the embryos every five minutes. This way, the embryologists can detect embryo cell movements and differentiate when embryo division occurs, without having to take the embryo out of the incubator and therefore alter the conditions of the in vitro culture
GERI PLUS VS OTHER INCUBATION SYSTEMS
Geri Plus has two essential improvements:
- 6 individual incubators: each patient has a unique space for her embryos, so embryo retrieval from other patients does not interfere with her
- Eeva Test: software that allows predicting the development potential of each embryo and classifying it. The test was developed at Stanford University and it has 85% efficacy
